H. Stöger

发表

Abstract S2-06: Survival advantage of anastrozol compared to tamoxifen for lobular breast cancer in the ABCSG-8 study

R. Greil, M. Gnant, Z. Bago-Horvath, 2015 .

The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

R. Greil, M. Gnant, H. Samonigg, 2013, British Journal of Cancer.

Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.

A. Gerger, J. Szkandera, M. Pichler, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?

A. Gerger, J. Szkandera, M. Stotz, 2017, Clinical orthopaedics and related research.

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer

R. Stupp, H. Moch, M. van den Broek, 2017, Oncoimmunology.

Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

R. Greil, M. Gnant, H. Samonigg, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.

R. Kreutz, C. Ay, H. Stöger, 2019, International journal of cardiology.

Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.

R. Greil, M. Gnant, H. Geinitz, 2020, European journal of cancer.

Sequential treatment of recurrent mesenteric desmoid tumor

H. Samonigg, G. Höfler, T. Bauernhofer, 1996, Cancer.

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy

A. Gerger, J. Szkandera, M. Stotz, 2020, Clinical and Translational Oncology.

Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

R. Greil, Michael Gnant, R. Exner, 2021, Breast Care.

Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study

H. Samonigg, F. Ploner, A. Kasparek, 2004, Cancer Chemotherapy and Pharmacology.

A phase I/II study of 4′-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients

H. Samonigg, T. Bauernhofer, F. Ploner, 2004, Cancer Chemotherapy and Pharmacology.

Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy

A. Gerger, J. Szkandera, M. Stotz, 2020, Scientific Reports.

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

R. Kreutz, C. Ay, H. Stöger, 2019, Research and practice in thrombosis and haemostasis.

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

R. Greil, M. Gnant, H. Samonigg, 2013, British Journal of Cancer.

R. Greil, Michael Gnant, R. Exner, 2021, Breast Care.

Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial

R. Greil, M. Gnant, P. Dubsky, 2018 .

Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors

K. Pummer, A. Gerger, J. Szkandera, 2019, AntiCancer Research.

Angiogenesis as a therapeutic target in advanced breast cancer

H. Stöger, K. Hegenbarth, H. Stöger, 2008 .

Breast cancer—advanced stage: “cure—still a long way to go?”

H. Stöger, H. Stöger, 2012, memo - Magazine of European Medical Oncology.

Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report.

E. Petru, H. Stöger, V. Bjelic-Radisic, 2006, Anticancer research.

Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas

T. Bauernhofer, T. Brodowicz, F. Ploner, 2014, Anti-cancer drugs.

Long-term cardiovascular complications in stage I seminoma patients

K. Pummer, A. Gerger, J. Szkandera, 2017, Clinical and Translational Oncology.

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors

K. Pummer, A. Gerger, B. Zurl, 2018, Cancer medicine.

Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.

T. H. Klotz, S. Culine, J. Hainsworth, 2022, The Lancet. Oncology.

First-Line Monochemotherapy with Mitoxantroneversus Combination with Fluorouracil, Epirubicin and Cyclophosphamide in High-Risk Metastatic Breast Cancer: A Prospective Randomized Multicenter Clinical Trial

R. Souchon, A. Scharl, M. Kaufmann, 2000, Oncology Research and Treatment.

Adjuvant radiotherapy in male breast cancer.

F. Quehenberger, H. Stöger, A. Hackl, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Benefit of Adjuvant Radiotherapy for Local Control, Distant Metastasis, and Survival Outcomes in Patients with Localized Soft Tissue Sarcoma: Comparative Effectiveness Analysis of an Observational Cohort Study

A. Gerger, J. Szkandera, M. Stotz, 2017, Annals of Surgical Oncology.

Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer

H. Samonigg, A. Kasparek, H. Stöger, 2004, Cancer Chemotherapy and Pharmacology.

Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer

P. Kornprat, A. Gerger, J. Szkandera, 2018, Wiener klinische Wochenschrift.

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients

P. Kornprat, A. Gerger, J. Szkandera, 2020, Cancers.